Neurology
1 drug is in development for Obstructive Sleep Apnea.
- Companies
- 1
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Obstructive Sleep Apnea pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ihl-42x | Incannex Healthcare Inc. (IXHL) |
About this indication
Obstructive Sleep Apnea context
Neurology·MeSH: Sleep Apnea, Obstructive (D020181)
Also known as: Apneas, Obstructive Sleep, OSAHS, Obstructive Sleep Apnea Syndrome, Sleep Apnea Hypopnea Syndrome, Syndrome, Sleep Apnea, Obstructive
Prevalence
15000.0 / 100K
Incidence
1000.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Obstructive Sleep Apnea?
BioSniper tracks 1 drug in development for Obstructive Sleep Apnea across 1 company.
How many clinical trials target Obstructive Sleep Apnea?
There are 19 clinical trials targeting Obstructive Sleep Apnea tracked by BioSniper.
What is the prevalence of Obstructive Sleep Apnea?
The estimated prevalence of Obstructive Sleep Apnea is approximately 15000.0 per 100,000 population.